Emerging approaches for the treatment of hypertriglyceridemia.

Abstract

Hypertriglyceridemia is frequent in diabetic and obese subjects, who are at increased risk for cardiovascular diseases (CVD). Increased triglycerides (TG) are a hallmark of atherogenic dyslipidemia, representing a marker of atherogenic small dense low-density lipoproteins (sdlDL). Importantly, non-fasting/postprandial TG measurements tend to be emphasized… (More)
DOI: 10.1517/14656566.2013.823402

Topics

  • Presentations referencing similar topics